Received May 11, 2026
Reports are unverified and do not show that a vaccine caused an event. Full disclaimer
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| VARZOS | ZOSTER (SHINGRIX) | GLAXOSMITHKLINE BIOLOGICALS | UNK | — | — |
Muscle ache; This non-serious case was reported by a consumer and described the occurrence of muscle pain in a 75-year-old male patient who received Herpes zoster (Shingrix) for prophylaxis. On 04-MAY-2026, the patient received Shingrix .5 ml. On 04-MAY-2026, less than a day after receiving Shingrix, the patient experienced muscle pain (Verbatim: Muscle ache). The outcome of the muscle pain was not resolved. It was unknown if the reporter considered the muscle pain to be related to Shingrix. It was unknown if the company considered the muscle pain to be related to Shingrix. Additional Information: GSK Receipt Date: 04-MAY-2026 The batch number was not provided upon follow- up with the reporter.